Skip to main content

Peer Review reports

From: The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

Original Submission
24 Feb 2012 Submitted Original manuscript
1 Mar 2012 Author responded Author comments - Daniel Murphy
Resubmission - Version 2
1 Mar 2012 Submitted Manuscript version 2
3 May 2012 Reviewed Reviewer Report - Peter Vestergaard
4 May 2012 Reviewed Reviewer Report - Jan Sorensen
Resubmission - Version 3
Submitted Manuscript version 3
18 Jun 2012 Author responded Author comments - Daniel Murphy
Resubmission - Version 4
18 Jun 2012 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
22 Jun 2012 Reviewed Reviewer Report - Peter Vestergaard
6 Jul 2012 Reviewed Reviewer Report - Jan Sorensen
3 Oct 2012 Author responded Author comments - Daniel Murphy
Resubmission - Version 6
3 Oct 2012 Submitted Manuscript version 6
4 Oct 2012 Author responded Author comments - Daniel Murphy
Resubmission - Version 7
4 Oct 2012 Submitted Manuscript version 7
Publishing
9 Oct 2012 Editorially accepted
30 Oct 2012 Article published 10.1186/1471-2474-13-213

You can find further information about peer review here.

Back to article page